AngioDynamics, Inc. (ANGO) Key Metrics
ANGO valuation today
Trailing 12 months · as of October 18, 2026- Market cap
- $472.7M
- Enterprise value
- $601.3M
- P/E (TTM)
- —
- Forward P/E
- 96.2
- PEG ratio
- 1.41
- Price / sales
- 1.5 10-yr median 1.5
- Price / book
- 3.8 10-yr median 1.3
- EV / EBITDA
- — 10-yr median 69.2
- Dividend yield
- —
- Beta
- 0.30
ANGO key metrics, FY2017–FY2026
Fiscal year ended May 31, 2026 · U.S. dollarsANGO valuation Price multiples at each fiscal year-end price.
Price / sales+4.2%
1.5
FY2026 · hover or tap a bar for each year
FY2017FY2026
Price / book+22.1%
2.8
FY2026 · hover or tap a bar for each year
FY2017FY2026
EV / EBITDA+304.5%
866.5
FY2026 · hover or tap a bar for each year
FY2017FY2026
Price / free cash flow
938.4
FY2026 · hover or tap a bar for each year
FY2017FY2026
Free cash flow yield+3.6 pts
0.1%
FY2026 · hover or tap a bar for each year
FY2017FY2026
ANGO returns How much profit the business earns on the capital it uses.
Return on equity−3.3 pts
−20.8%
FY2026 · hover or tap a bar for each year
FY2017FY2026
Return on invested capital−1.6 pts
−24.8%
FY2026 · hover or tap a bar for each year
FY2017FY2026
Return on assets−2.1 pts
−13.4%
FY2026 · hover or tap a bar for each year
FY2017FY2026
Free cash flow margin+5.1 pts
0.2%
FY2026 · hover or tap a bar for each year
FY2017FY2026
Asset turnover+19.6%
1.17
FY2026 · hover or tap a bar for each year
FY2017FY2026
ANGO per-share figures Results divided by the shares outstanding at year-end.
Revenue per share+8.0%
$7.71
FY2026 · hover or tap a bar for each year
FY2017FY2026
Earnings per share
−$0.88
FY2026 · hover or tap a bar for each year
FY2017FY2026
Free cash flow per share
$0.01
FY2026 · hover or tap a bar for each year
FY2017FY2026
Book value per share−7.9%
$4.11
FY2026 · hover or tap a bar for each year
FY2017FY2026
Shares outstanding+1.3%
41.5M
FY2026 · hover or tap a bar for each year
FY2017FY2026
ANGO financial health Debt, liquidity and how easily interest is covered.
Net debt−$8.1M
−$53.9M
FY2026 · hover or tap a bar for each year
FY2017FY2026
Net debt / EBITDA−84.06
−110.38
FY2026 · hover or tap a bar for each year
FY2017FY2026
Current ratio−1.0%
2.19
FY2026 · hover or tap a bar for each year
FY2017FY2026
Interest coverage
-133.5
FY2026 · hover or tap a bar for each year
FY2017FY2026
ANGO efficiency & capital use Working capital cycle and where the cash goes.
Days sales outstanding−6 days
52 days
FY2026 · hover or tap a bar for each year
FY2017FY2026
Days of inventory−22 days
144 days
FY2026 · hover or tap a bar for each year
FY2017FY2026
Days payables outstanding−15 days
81 days
FY2026 · hover or tap a bar for each year
FY2017FY2026
Cash conversion cycle−13 days
114 days
FY2026 · hover or tap a bar for each year
FY2017FY2026
Capex / revenue−0.7 pts
0.8%
FY2026 · hover or tap a bar for each year
FY2017FY2026
Dividends + buybacks / FCF
0.0%
FY2026 · hover or tap a bar for each year
FY2017FY2026
ANGO valuation history
Fiscal year-endToday10-year median
ANGO returns on capital
ROEROICROA
Net income (ROE, ROA) or after-tax operating income (ROIC) divided by the average of the opening and closing balance.
ANGO debt vs cash
Total debtCash & short-term investments
Debt includes short- and long-term borrowings and, where reported, lease liabilities.
ANGO cash returned to shareholders
DividendsBuybacksFree cash flow
ANGO price vs earnings per share
Share price at year-endEPS (right axis)
ANGO key metrics
FY2017–FY2026| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||
| Market capitalization | $476.7M | $418.0M | $253.5M | $373.5M | $765.8M | $886.5M | $387.6M | $704.3M | $789.4M | $557.3M |
| Enterprise value | $422.9M | $372.3M | $182.2M | $393.4M | $770.7M | $860.7M | $374.0M | $613.2M | $807.8M | $614.5M |
| P/E ratio | — | — | — | — | — | — | — | 11.5 | 48.3 | — |
| Price / sales | 1.5 | 1.4 | 0.8 | 1.1 | 2.4 | 3.0 | 1.5 | 2.0 | 2.3 | 1.6 |
| Price / book | 2.8 | 2.3 | 1.2 | 1.0 | 1.8 | 2.0 | 0.9 | 1.1 | 1.5 | 1.1 |
| Price / free cash flow | 938.4 | — | — | — | — | 46.9 | — | 20.5 | 21.0 | 10.6 |
| Price / operating cash flow | 154.3 | — | — | — | — | 36.8 | — | 18.8 | 19.1 | 10.0 |
| EV / sales | 1.3 | 1.3 | 0.6 | 1.2 | 2.4 | 3.0 | 1.4 | 1.7 | 2.3 | 1.8 |
| EV / EBITDA | 866.5 | 214.2 | — | 32.3 | 69.2 | — | — | 37.7 | 90.1 | 46.0 |
| EV / free cash flow | 832.4 | — | — | — | — | 45.5 | — | 17.9 | 21.5 | 11.7 |
| Earnings yield | −7.7% | −8.1% | −72.7% | −14.0% | −3.5% | −3.6% | −43.0% | 8.7% | 2.1% | −1.3% |
| Free cash flow yield | 0.1% | −3.5% | −13.4% | −1.1% | −1.5% | 2.1% | −5.7% | 4.9% | 4.8% | 9.5% |
| Dividend yield | — | — | — | — | — | — | — | — | 0.0% | 0.0% |
| Shareholder yield (dividends + buybacks) | 0.0% | 0.4% | 0.0% | 0.0% | — | — | 0.2% | 0.0% | 0.0% | 2.4% |
| Share price at fiscal year-end | $11.48 | $10.20 | $6.31 | $9.46 | $19.63 | $23.12 | $10.21 | $18.79 | $21.03 | $15.08 |
| Per share | ||||||||||
| Revenue per share | $7.71 | $7.14 | $7.56 | $8.58 | $8.11 | $7.59 | $6.96 | $9.59 | $9.17 | $9.46 |
| Earnings per share | −$0.88 | −$0.83 | −$4.59 | −$1.33 | −$0.68 | −$0.82 | −$4.39 | $1.64 | $0.44 | −$0.19 |
| Operating cash flow per share | $0.07 | −$0.25 | −$0.70 | $0.00 | −$0.18 | $0.63 | −$0.38 | $1.00 | $1.10 | $1.51 |
| Free cash flow per share | $0.01 | −$0.36 | −$0.84 | −$0.11 | −$0.29 | $0.49 | −$0.58 | $0.92 | $1.00 | $1.43 |
| Cash per share | $1.30 | $1.36 | $1.89 | $1.13 | $0.74 | $1.26 | $1.43 | $6.07 | $2.01 | $1.32 |
| Book value per share | $4.11 | $4.46 | $5.12 | $9.58 | $10.88 | $11.46 | $12.01 | $16.40 | $14.45 | $13.99 |
| Tangible book value per share | $2.50 | $2.78 | $3.19 | $2.73 | $1.82 | $1.80 | $1.51 | $3.25 | $1.36 | $0.27 |
| Dividends per share | — | — | — | — | — | — | — | — | $0.00 | $0.00 |
| Capex per share | $0.06 | $0.11 | $0.14 | $0.11 | $0.11 | $0.14 | $0.20 | $0.08 | $0.10 | $0.08 |
| Debt per share | — | $0.25 | $0.12 | $1.64 | $0.87 | $0.58 | $1.08 | $3.64 | $2.50 | $2.87 |
| Shares outstanding | 41.5M | 41.0M | 40.2M | 39.5M | 39.0M | 38.3M | 38.0M | 37.5M | 37.5M | 37.0M |
| Change in shares outstanding | +1.3% | +2.0% | +1.8% | +1.2% | +1.7% | +1.0% | +1.3% | −0.1% | +1.6% | +2.2% |
| Returns & profitability | ||||||||||
| Return on equity (ROE) | −20.8% | −17.5% | −63.1% | −13.1% | −6.1% | −7.0% | −31.2% | 10.6% | 3.1% | −1.4% |
| Return on invested capital (ROIC) | −24.8% | −23.3% | −57.1% | −9.8% | −5.3% | −6.5% | −27.3% | −1.4% | −2.0% | −1.5% |
| Return on assets (ROA) | −13.4% | −11.4% | −43.4% | −9.7% | −4.8% | −5.5% | −23.3% | 8.0% | 2.3% | −1.0% |
| Return on tangible assets | −18.4% | −16.1% | −76.7% | −20.0% | −13.3% | −16.5% | −84.7% | 17.9% | 7.6% | −3.5% |
| Free cash flow margin | 0.2% | −5.0% | −11.2% | −1.3% | −3.6% | 6.5% | −8.4% | 9.5% | 10.9% | 15.1% |
| Income quality (OCF / net income) | — | — | — | — | — | — | — | 0.61 | 2.53 | — |
| Financial health | ||||||||||
| Total debt | — | $10.1M | $4.7M | $64.6M | $33.8M | $22.4M | $40.8M | $136.5M | $93.7M | $105.9M |
| Cash & short-term investments | $53.9M | $55.9M | $76.1M | $44.6M | $28.8M | $48.2M | $54.4M | $227.6M | $75.4M | $48.8M |
| Net debt | −$53.9M | −$45.7M | −$71.3M | $20.0M | $5.0M | −$25.7M | −$13.6M | −$91.1M | $18.3M | $57.2M |
| Debt / equity | — | 0.06 | 0.02 | 0.17 | 0.08 | 0.05 | 0.09 | 0.22 | 0.17 | 0.20 |
| Debt / assets | — | 0.04 | 0.01 | 0.12 | 0.06 | 0.04 | 0.07 | 0.16 | 0.13 | 0.15 |
| Net debt / EBITDA | −110.38 | −26.32 | — | 1.64 | 0.45 | — | — | −5.60 | 2.04 | 4.28 |
| Current ratio | 2.19 | 2.21 | 2.12 | 1.95 | 1.93 | 2.45 | 2.97 | 4.30 | 2.93 | 2.21 |
| Quick ratio | 1.49 | 1.40 | 1.46 | 1.29 | 1.24 | 1.60 | 1.80 | 3.75 | 2.25 | 1.43 |
| Interest coverage | -133.5 | — | -119.2 | -18.9 | -41.4 | -41.0 | -184.2 | -1.8 | -4.6 | -3.9 |
| Working capital | $88.7M | $92.1M | $102.1M | $79.7M | $69.0M | $83.3M | $101.4M | $242.0M | $110.7M | $84.4M |
| Invested capital | $117.0M | $137.2M | $134.3M | $398.3M | $429.4M | $413.7M | $442.3M | $523.7M | $560.9M | $574.2M |
| Tangible asset value | $103.6M | $113.9M | $128.2M | $107.9M | $71.1M | $69.2M | $57.2M | $121.8M | $51.0M | $10.1M |
| Net current asset value | $67.1M | $71.2M | $81.2M | $9.2M | $15.1M | $18.9M | $13.3M | $93.7M | $5.2M | −$37.0M |
| Graham number | — | — | — | — | — | — | — | $24.57 | $11.90 | — |
| Graham net-net per share | $0.48 | $0.54 | $0.79 | −$1.07 | −$0.80 | −$0.60 | −$0.78 | $1.57 | −$1.02 | −$2.17 |
| Capital allocation | ||||||||||
| Dividends paid | — | — | — | — | — | — | — | — | $0 | $0 |
| Share buybacks (net) | $0 | $1.7M | $0 | $0 | — | — | $759,000 | $0 | $0 | $13.6M |
| Dividend payout ratio | — | — | — | — | — | — | — | — | 0.0% | — |
| Dividends + buybacks / free cash flow | 0.0% | — | — | — | — | — | — | 0.0% | 0.0% | 25.7% |
| Capex / revenue | 0.8% | 1.5% | 1.9% | 1.3% | 1.4% | 1.8% | 2.9% | 0.9% | 1.1% | 0.9% |
| Capex / operating cash flow | 83.6% | — | — | 5,579.5% | — | 21.5% | — | 8.3% | 8.9% | 5.4% |
| Capex / depreciation | 0.11 | 0.17 | 0.21 | 0.14 | 0.15 | 0.20 | 0.32 | 0.12 | 0.16 | 0.12 |
| Stock-based compensation / revenue | 4.4% | 3.3% | 3.5% | 3.3% | 3.4% | 3.0% | 2.9% | 2.6% | 2.3% | 1.8% |
| R&D / revenue | 9.2% | 9.0% | 10.4% | 8.8% | 9.7% | 12.5% | 11.2% | 8.2% | 7.4% | 7.2% |
| SG&A / revenue | 49.1% | 49.7% | 47.4% | 42.6% | 42.3% | 40.3% | 44.1% | 32.3% | 31.5% | 31.5% |
| Efficiency | ||||||||||
| Days sales outstanding | 52.1 | 58.1 | 61.8 | 58.9 | 53.0 | 43.6 | 53.7 | 42.1 | 45.5 | 51.8 |
| Days of inventory on hand | 143.8 | 166.0 | 141.8 | 118.4 | 121.3 | 147.6 | 160.2 | 126.3 | 145.3 | 159.4 |
| Days payables outstanding | 81.4 | 96.2 | 95.6 | 76.0 | 57.8 | 52.7 | 67.2 | 61.5 | 52.5 | 48.9 |
| Cash conversion cycle (days) | 114.5 | 128.0 | 107.9 | 101.3 | 116.5 | 138.5 | 146.7 | 107.0 | 138.3 | 162.3 |
| Receivables turnover | 7.00 | 6.28 | 5.91 | 6.20 | 6.88 | 8.36 | 6.79 | 8.66 | 8.03 | 7.05 |
| Payables turnover | 4.48 | 3.79 | 3.82 | 4.80 | 6.31 | 6.93 | 5.43 | 5.94 | 6.96 | 7.47 |
| Inventory turnover | 2.54 | 2.20 | 2.57 | 3.08 | 3.01 | 2.47 | 2.28 | 2.89 | 2.51 | 2.29 |
| Asset turnover | 1.17 | 0.98 | 0.71 | 0.62 | 0.57 | 0.50 | 0.37 | 0.47 | 0.49 | 0.49 |
| Average receivables | $45.7M | $46.6M | $51.4M | $54.7M | $46.0M | $34.8M | $38.9M | $41.5M | $42.9M | $49.6M |
| Average payables | $32.4M | $35.5M | $39.1M | $34.2M | $23.8M | $19.4M | $21.0M | $19.3M | $16.9M | $16.9M |
| Average inventory | $57.2M | $61.3M | $58.0M | $53.4M | $50.0M | $54.3M | $50.0M | $39.7M | $46.9M | $54.9M |
| Intangibles / total assets | 25.2% | 24.7% | 24.4% | 50.8% | 63.9% | 66.0% | 66.9% | 58.9% | 69.7% | 71.6% |
Computed from ANGO's annual financial statements (latest annual report filed July 14, 2026) and the closing share price on each fiscal year-end, adjusted for stock splits. Figures in U.S. dollars; data from EODHD. Averages use the opening and closing balance of each year.
ANGO valuation and financial ratios
AngioDynamics earned a return on equity of −20.8% and a return on invested capital of −24.8% in fiscal 2026. The share count rose 12.4% from 37.0M to 41.5M over 9 years.
See the ANGO income statement, the ANGO chart for price history, or the ANGO stock overview for the latest quote and news.
ANGO key metrics FAQ
What is AngioDynamics's EV/EBITDA?
AngioDynamics's enterprise value was 866.5 times EBITDA at the end of fiscal 2026 (enterprise value $422.9 million, EBITDA $0.5 million).
What is AngioDynamics's return on equity?
AngioDynamics's return on equity (ROE) was −20.8% in fiscal 2026: net income of -$36.7 million on average shareholders' equity of $176.9 million.
What is AngioDynamics's ROIC?
AngioDynamics's return on invested capital was −24.8% in fiscal 2026, using after-tax operating income divided by average debt plus equity minus cash.
What is AngioDynamics's free cash flow yield?
AngioDynamics generated $0.5 million of free cash flow in fiscal 2026, a free cash flow yield of 0.1% on its market value at year-end ($476.7 million).
What is AngioDynamics's current ratio?
AngioDynamics's current ratio was 2.19 at the end of fiscal 2026: current assets were 2.19 times current liabilities.